Intech Investment Management LLC Sells 132,517 Shares of Select Medical Holdings Corporation $SEM

Intech Investment Management LLC cut its stake in Select Medical Holdings Corporation (NYSE:SEM) by 72.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 50,839 shares of the health services provider’s stock after selling 132,517 shares during the quarter. Intech Investment Management LLC’s holdings in Select Medical were worth $755,000 as of its most recent SEC filing.

A number of other institutional investors also recently bought and sold shares of the stock. Royal Bank of Canada increased its stake in Select Medical by 8.5% in the first quarter. Royal Bank of Canada now owns 95,771 shares of the health services provider’s stock worth $1,599,000 after purchasing an additional 7,502 shares during the period. AQR Capital Management LLC increased its stake in Select Medical by 96.6% in the first quarter. AQR Capital Management LLC now owns 33,894 shares of the health services provider’s stock worth $566,000 after purchasing an additional 16,656 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in Select Medical by 4.6% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 64,400 shares of the health services provider’s stock worth $1,075,000 after purchasing an additional 2,809 shares during the period. Dynamic Technology Lab Private Ltd purchased a new stake in Select Medical in the first quarter worth $220,000. Finally, Goldman Sachs Group Inc. increased its stake in Select Medical by 25.3% in the first quarter. Goldman Sachs Group Inc. now owns 728,689 shares of the health services provider’s stock worth $12,169,000 after purchasing an additional 147,183 shares during the period. 89.48% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on SEM. Royal Bank Of Canada reiterated a “sector perform” rating and issued a $16.50 target price (down from $19.00) on shares of Select Medical in a research note on Tuesday, March 3rd. Zacks Research upgraded Select Medical from a “strong sell” rating to a “hold” rating in a research note on Monday, May 4th. Wall Street Zen lowered Select Medical from a “buy” rating to a “hold” rating in a research note on Monday, March 9th. Mizuho reiterated a “neutral” rating and issued a $16.50 target price (down from $17.00) on shares of Select Medical in a research note on Tuesday, May 12th. Finally, Weiss Ratings upgraded Select Medical from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday. One analyst has rated the stock with a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $15.50.

Select Medical Price Performance

SEM opened at $16.59 on Tuesday. Select Medical Holdings Corporation has a 12-month low of $11.65 and a 12-month high of $16.99. The company has a current ratio of 1.15, a quick ratio of 1.15 and a debt-to-equity ratio of 0.88. The business’s fifty day simple moving average is $16.44 and its 200-day simple moving average is $15.75. The company has a market capitalization of $2.06 billion, a price-to-earnings ratio of 15.65, a PEG ratio of 0.95 and a beta of 1.01.

Select Medical (NYSE:SEM) last posted its quarterly earnings results on Thursday, April 30th. The health services provider reported $0.36 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.43 by ($0.07). Select Medical had a return on equity of 6.62% and a net margin of 2.42%.The firm had revenue of $1.42 billion for the quarter, compared to the consensus estimate of $1.41 billion. During the same period in the previous year, the company posted $0.44 EPS. Select Medical’s quarterly revenue was up 5.0% compared to the same quarter last year. Select Medical has set its FY 2026 guidance at 1.220-1.320 EPS. On average, equities research analysts anticipate that Select Medical Holdings Corporation will post 1.26 earnings per share for the current fiscal year.

Select Medical announced that its Board of Directors has authorized a share repurchase plan on Thursday, February 19th that authorizes the company to buyback $1.00 billion in outstanding shares. This buyback authorization authorizes the health services provider to buy up to 49.5% of its shares through open market purchases. Shares buyback plans are usually an indication that the company’s board of directors believes its shares are undervalued.

Select Medical Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, May 28th. Stockholders of record on Thursday, May 14th were given a dividend of $0.0625 per share. The ex-dividend date of this dividend was Thursday, May 14th. This represents a $0.25 dividend on an annualized basis and a dividend yield of 1.5%. Select Medical’s dividend payout ratio is presently 23.58%.

About Select Medical

Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.

Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.